⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

BriaCell Therapeutics Corp. Warrant expiring 2031

$0.9000
-0.0001 (-0.01%)

Volume:

22.939K ($20.69K)

Market Capitalization:

-

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

BriaCell Therapeutics Corp. Warrant expiring 2031 Market Segments

Regular Trading Hours

-0.0300(-3.23%)
Open$0.9300
Close$0.9000
Low$0.9000
Low Change-0.0300 (-3.23%)
High$0.9400
High Change+0.0100 (+1.08%)
Range$0.0400
Volume21.539K
Dollar Volume$19.39K

Premarket

+0.0100(+1.09%)
Open$0.9200
Close$0.9300
Low$0.9200
Low Change0.0000 (0.00%)
High$0.9300
High Change+0.0100 (+1.09%)
Range$0.0100
Volume1.4K
Dollar Volume$1.30K

Overnight

*No Trades in Segment

After Hours Yesterday

*No Trades in Segment

Regular Trading Hours Yesterday

-0.1499(-14.28%)
Open$1.0500
Close$0.9001
Low$0.9000
Low Change-0.1500 (-14.29%)
High$1.0500
High Change+0.0000 (+0.00%)
Range$0.1500
Volume41.959K
Dollar Volume$37.77K

Premarket Yesterday

+0.0000(+0.00%)
Open$1.1499
Close$1.1499
Low$1.1499
Low Change0.0000 (0.00%)
High$1.1499
High Change+0.0000 (+0.00%)
Range$0.0000
Volume600
Dollar Volume$689.94

BriaCell Therapeutics Corp. Warrant expiring 2031 News

There is no current news for this stock at the moment.

BriaCell Therapeutics Corp. Warrant expiring 2031 Top Trades

BriaCell Therapeutics Corp. Warrant expiring 2031's top trade so far today returned +2.17%, while the top short trade returned -4.26%.

BriaCell Therapeutics Corp. Warrant expiring 2031 Moving Averages

5 Day Moving Average (SMA5)$1.0382
10 Day Moving Average (SMA10)$1.1046
20 Day Moving Average (SMA20)$1.0821
50 Day Moving Average (SMA50)$0.9833
100 Day Moving Average (SMA100)$0.9224
200 Day Moving Average (SMA200)—

BriaCell Therapeutics Corp. Warrant expiring 2031 Statistics

Average Volume (30 Days)12.28K
P/E Ratio (Current)—
EPS (Current)—
Dividend Yield—
Free Cash Flow-$30.95M
Cash Ratio1.92
Current Ratio7.07
Quick Ratio7.07
Debt to Equity0.00
Enterprise Value—
EV to EBITDA—
EV to Sales—
Price to Book—
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets-1.13%
Return on Equity-1.28%

BriaCell Therapeutics Corp. Warrant expiring 2031 Stock Splits

There have been no stock splits for BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL).

BriaCell Therapeutics Corp. Warrant expiring 2031 Dividends

There have been no dividends for BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL).